| Literature DB >> 25939753 |
Filip Bednar1, Heather K Schofield2, Meredith A Collins3, Wei Yan4, Yaqing Zhang1, Nikhil Shyam5, Jaime A Eberle6, Luciana L Almada7, Kenneth P Olive6, Nabeel Bardeesy8, Martin E Fernandez-Zapico7, Daisuke Nakada9, Diane M Simeone10, Sean J Morrison11, Marina Pasca di Magliano12.
Abstract
Epigenetic dysregulation is involved in the initiation and progression of many epithelial cancers. BMI1, a component of the polycomb protein family, plays a key role in these processes by controlling the histone ubiquitination and long-term repression of multiple genomic loci. BMI1 has previously been implicated in pancreatic homeostasis and the function of pancreatic cancer stem cells. However, no work has yet addressed its role in the early stages of pancreatic cancer development. Here, we show that BMI1 is required for the initiation of murine pancreatic neoplasia using a novel conditional knockout of Bmi1 in combination with a Kras(G12D)-driven pancreatic cancer mouse model. We also demonstrate that the requirement for Bmi1 in pancreatic carcinogenesis is independent of the Ink4a/Arf locus and at least partially mediated by dysregulation of reactive oxygen species. Our data provide new evidence of the importance of this epigenetic regulator in the genesis of pancreatic cancer.Entities:
Mesh:
Substances:
Year: 2015 PMID: 25939753 PMCID: PMC4566095 DOI: 10.1093/carcin/bgv058
Source DB: PubMed Journal: Carcinogenesis ISSN: 0143-3334 Impact factor: 4.944